Chairman of the Board

Mr. Baruch founded CMEA Capital in 1989 as an affiliated fund of New Enterprise Associates (NEA). Before starting CMEA Capital, he was a founder and CEO of Microwave Technology, a manufacturer of gallium arsenide semiconductor integrated circuits. Prior to that, he managed a dedicated venture fund at Exxon and was president of the Exxon Materials Division. Earlier in his career, he worked as a patent attorney. Mr. Baruch holds an engineering degree from Rensselaer Polytechnic Institute and a J.D. degree from Capital University. At CMEA Capital, he was one of the original investors in Aclara Biosciences (which merged with Monogram Biosciences - NASDAQ: MRGM), Flextronics (FLEX), Netro (NTRO), Silicon Spice (acquired by BRCM), and Symyx Technologies (SMMX).  In addition to chairing Intermolecular’s board, he serves as Chairman of  CMEA’s materials  and energy companies including: Codexis, Inc., Cnano Technologies and Wildcat Discovery Technologies. Tom also currently serves on the boards of Biolight, Draths, Entropic Communications (ENTR), Exela, Luminus Devices, Solyndra and Superprotonic.  An area of special interest to Mr. Baruch is an innovative process for developing new chemical compounds called combinatorial synthesis. It applies a convergence of genomics, Moore’s law hardware and custom software to enable very rapid screening of new materials. Tom has pioneered CMEA’s investments in companies that apply combinatorial synthesis including Codexis, Draths, Intermolecular, Symyx, Syryx and Wildcat Discovery. Mr. Baruch is a registered patent attorney and is also a member of the Board of Trustees of Rensselaer Polytechnic Institute.  Tom also serves as a board member of the Energy, Security, Innovation and Sustainability (ESIS) Initiative Steering Committee of the Council on Competitiveness.